UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ChatGPT—A promising generative AI tool and its implications for cancer care

Cancer, 2023-08, Vol.129 (15), p.2284-2289

2023

Volltextzugriff (PDF)

Maintenance of Certification (MOC)-Benefit vs Burden

JAMA : the journal of the American Medical Association, 2023-10, Vol.330 (14), p.1329

2023

Volltextzugriff (PDF)

Lessons From ADAURA on Adjuvant Cancer Drug Trials: Evidence, Ethics, and Economics

Journal of clinical oncology, 2021-01, Vol.39 (3), p.175-177

2021

Volltextzugriff (PDF)

Lessons from ADAURA: Can we improve on a positive trial?

Cancer, 2024-03, Vol.130 (5), p.659-664

2024

Volltextzugriff (PDF)

ABIM Maintenance of Certification-Reply

JAMA : the journal of the American Medical Association, 2024-01, Vol.331 (3), p.261

2024

Volltextzugriff (PDF)

Examining crossover and postprotocol therapies in first‐line immunotherapy trials in non–small cell lung cancer

Cancer, 2024-08, Vol.130 (16), p.2807-2811

2024

Volltextzugriff (PDF)

Farewell and Thank You from the Outgoing Editor-in-Chief

Employee responsibilities and rights journal, 2023-12, Vol.35 (4), p.433-433

L. Howard, Jack

2023

Volltextzugriff (PDF)

Clinical Decision-Making in the Real World—The Perfect as the Enemy of the Good

JAMA oncology, 2023-08, Vol.9 (8), p.1082

West, Howard (Jack)

2023

Volltextzugriff (PDF)

Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era

Frontiers in oncology, 2020-09, Vol.10, p.578888-578888

West, Howard (Jack)

2020

Volltextzugriff (PDF)

Novel Precision Medicine Trial Designs: Umbrellas and Baskets

JAMA oncology, 2017-03, Vol.3 (3), p.423

West, Howard (Jack)

2017

Volltextzugriff (PDF)

Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?

Current oncology reports, 2022-12, Vol.24 (12), p.1843-1850

2022

Volltextzugriff (PDF)

Postoperative Radiation Therapy Should Be Used for Completely Resected Stage III-N2 NSCLC in Select Patients

Journal of thoracic oncology, 2022-02, Vol.17 (2), p.194-196

2022

Volltextzugriff (PDF)

Adolescents and Young Adults With Cancer

JAMA oncology, 2023-03, Vol.9 (3), p.440

2023

Volltextzugriff (PDF)

Molecular Marker Testing in Curable Non-Small Cell Lung Cancer-Practice Necessarily Precedes Data

JAMA oncology, 2023-06, Vol.9 (6), p.758

2023

Volltextzugriff (PDF)

Tumor Mutation Burden and Cancer Treatment

JAMA oncology, 2021-02, Vol.7 (2), p.316

2021

Volltextzugriff (PDF)

Malignant Pericardial Effusion, or Fluid Around the Heart Due to Cancer

JAMA oncology, 2024-01, Vol.10 (1), p.148

2024

Volltextzugriff (PDF)

Brief Report on Global Clinician Practices in the First-Line Management of Metastatic Non-Small Cell Lung Cancer

Clinical lung cancer, 2024-11, Vol.25 (7), p.e286-e294

2024

Volltextzugriff (PDF)

Why Not Adore ADAURA?—The Trial We Need vs the Trial We Got

JAMA oncology, 2021-05, Vol.7 (5), p.677

2021

Volltextzugriff (PDF)

Can We Define and Reach Precise Goals for Precision Medicine in Cancer Care?

Journal of clinical oncology, 2016-10, Vol.34 (30), p.3595-3596

West, Howard Jack

2016

Volltextzugriff (PDF)

Perioperative Therapy for Resectable Non-Small-Cell Lung Cancer: Weighing Options for the Present and Future

JCO oncology practice, 2023-07, Vol.19 (7), p.403-409

2023

Volltextzugriff (PDF)

Rapid Advances in Resectable Non-Small Cell Lung Cancer: A Narrative Review

JAMA oncology, 2024-02, Vol.10 (2), p.249

2024

Volltextzugriff (PDF)

Febrile Neutropenia

JAMA oncology, 2017-12, Vol.3 (12), p.1751

2017

Volltextzugriff (PDF)

Cancer Care in the Era of Artificial Intelligence

JAMA oncology, 2024-05, Vol.10 (5), p.683

2024

Volltextzugriff (PDF)

Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities

JCO global oncology, 2023-09, Vol.9 (9), p.e2300344-e2300344

2023

Volltextzugriff (PDF)

Jarring Discordance Between Idealized and Real-World Management in Stage III Non-Small-Cell Lung Cancer

JCO oncology practice, 2020-10, Vol.16 (10), p.628-630

West, Howard Jack

2020

Volltextzugriff (PDF)

1 – 25 von 2.364

Menü

Weitere Dienste

Einstellungen

ChatGPT—A promising generative AI tool and its implications for cancer care

Maintenance of Certification (MOC)-Benefit vs Burden

Lessons From ADAURA on Adjuvant Cancer Drug Trials: Evidence, Ethics, and Economics

Lessons from ADAURA: Can we improve on a positive trial?

ABIM Maintenance of Certification-Reply

Examining crossover and postprotocol therapies in first‐line immunotherapy trials in non–small cell lung cancer

Farewell and Thank You from the Outgoing Editor-in-Chief

Clinical Decision-Making in the Real World—The Perfect as the Enemy of the Good

Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era

Novel Precision Medicine Trial Designs: Umbrellas and Baskets

Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?

Postoperative Radiation Therapy Should Be Used for Completely Resected Stage III-N2 NSCLC in Select Patients

Adolescents and Young Adults With Cancer

Molecular Marker Testing in Curable Non-Small Cell Lung Cancer-Practice Necessarily Precedes Data

Tumor Mutation Burden and Cancer Treatment

Malignant Pericardial Effusion, or Fluid Around the Heart Due to Cancer

Brief Report on Global Clinician Practices in the First-Line Management of Metastatic Non-Small Cell Lung Cancer

Why Not Adore ADAURA?—The Trial We Need vs the Trial We Got

Can We Define and Reach Precise Goals for Precision Medicine in Cancer Care?

Perioperative Therapy for Resectable Non-Small-Cell Lung Cancer: Weighing Options for the Present and Future

Rapid Advances in Resectable Non-Small Cell Lung Cancer: A Narrative Review

Febrile Neutropenia

Cancer Care in the Era of Artificial Intelligence

Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities

Jarring Discordance Between Idealized and Real-World Management in Stage III Non-Small-Cell Lung Cancer

Suchergebnisse filtern